Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study

BACKGROUND: The purpose of this study was to evaluate change in glycosylated hemoglobin (HbA1c), side effects, and quality of life (QOL) after a 16-week treatment period with Biphasic insulin aspart 30/70 (BIasp30) in patients with type 2 diabetes mellitus (T2DM) who had been suboptimally controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Kee-Ho, Kim, Jung Min, Noh, Jung-Hyun, Park, Yongsoo, Son, Hyun-Shik, Min, Kyong Wan, Ko, Kyung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638222/
https://www.ncbi.nlm.nih.gov/pubmed/23641352
http://dx.doi.org/10.4093/dmj.2013.37.2.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638222/
https://www.ncbi.nlm.nih.gov/pubmed/23641352
http://dx.doi.org/10.4093/dmj.2013.37.2.117

Ejemplares similares